Milestone Scientific to Exhibit at the California Dental Association (CDA) Spring Scientific Session
April 28 2008 - 9:30AM
PR Newswire (US)
LIVINGSTON, N.J., April 28 /PRNewswire-FirstCall/ -- Milestone
Scientific Inc. (OTC:MLSS) (BULLETIN BOARD: MLSS) , the recognized
leader in advanced injection technologies, today announced that it
will be showcasing and demonstrating its award winning STA(TM)
System at the upcoming California Dental Association (CDA) 2008
Spring Scientific Session. WHEN: Thursday, May 1- Sunday, May 4,
2008 WHERE: Booth #1641 Anaheim Convention Center 800 West Katella
Avenue Anaheim, California 92802 WHO: Bob Presutti, Vice President
of Sales & Marketing, Milestone Scientific Other Milestone
Executives Sales Representatives from Henry Schein, Inc. WHAT:
Demonstrations of the STA System -- According to a December 2007
article published in Contemporary Dental Assistant magazine, "The
(STA) instrument is highly effective in all areas of the oral
cavity, including those areas of dense connective tissue, such as
the hard palate. Dentists can provide traditional block anesthesia
and infiltration injections with this technology; however, special
techniques also may be employed to provide local anesthesia to the
precise teeth targeted for treatment via the periodontal ligament
(PDL) injection. The routine side effects of facial and lingual
numbness from a traditional anesthetic injection soon may be a
thing of the past." -- Learn first hand how Milestone is redefining
the standard of care of the delivery of local anesthesia in
dentistry. -- Discover how the STA System is improving patient care
and the dental practice efficiency for those dentists who have
adopted CCLAD (Computer Controlled Local Anesthesia Delivery)
technology to more comfortably administer all dental injections
performed in their dental operatories. NOTE TO PRESS: To arrange
one-on-one interviews with Mr. Presutti, or to schedule a personal
demonstration of the STA System, please contact John Morrison or
Tiffany Korkis, Directors, Elite Media Group, at 407-585-1080 or
via email at . The CDA Scientific Sessions are held twice a year --
once in the spring and once in the fall. These preeminent sessions
offer dynamic speakers, the finest technical exhibits available,
and the opportunity to fulfill continuing education requirements.
The exhibit hall will showcase approximately 600 vendors and
provide an excellent opportunity to review the latest technology
and services available to thousands of dental professionals. About
CDA The CDA is the largest statewide dental association in the
country. Its 24,000 members represent almost 70 percent of dentists
practicing in the state. The CDA organization is comprised of CDA,
the CDA Foundation, The Dentists Insurance Company and TDIC
Insurance Solutions. Founded in 1870, CDA is part of a membership
structure that includes 32 local dental societies and the American
Dental Association. CDA represents the single largest membership in
the American Dental Association. One out of seven ADA members is
also a member of CDA. About Milestone Scientific Inc. Headquartered
in Livingston, New Jersey, Milestone Scientific is engaged in
pioneering proprietary, highly innovative technological solutions
for the medical and dental markets. Central to the Company's IP
platform and product development strategy is its patented
CompuFlo(R) technology for the improved and painless delivery of
local anesthetic. Specifically, CompuFlo is a computer-controlled,
pressure sensitive infusion, perfusion, suffusion and aspiration
technology, which provides real-time readouts of pressures, fluid
densities and flow rates, enabling the advanced delivery and
removal of a wide array of fluids. The STA(TM) (Single Tooth
Anesthesia) System computer-controlled local anesthesia delivery
system which uses this technology provides dentists with audible
and visual signals as to in-tissue pressure. Milestone's existing
painless injection systems are currently sold in 25 countries. For
more information on these and other innovative Milestone products,
please visit the Company's web site found at
http://www.milesci.com/. Safe Harbor Statement This press release
contains forward-looking statements regarding the timing and
financial impact of the Milestone's ability to implement its
business plan, expected revenues and future success. These
statements involve a number of risks and uncertainties and are
based on assumptions involving judgments with respect to future
economic, competitive and market conditions and future business
decisions, all of which are difficult or impossible to predict
accurately and many of which are beyond Milestone's control. Some
of the important factors that could cause actual results to differ
materially from those indicated by the forward-looking statements
are general economic conditions, failure to achieve expected
revenue growth, changes in our operating expenses, adverse patent
rulings, FDA or legal developments, competitive pressures, changes
in customer and market requirements and standards, and the risk
factors detailed from time to time in Milestone's periodic filings
with the Securities and Exchange Commission, including without
limitation, Milestone's Annual Report on Form 10-KSB for the year
ended December 31, 2007. The forward looking-statements in this
press release are based upon management's reasonable belief as of
the date hereof. Milestone undertakes no obligation to revise or
update publicly any forward-looking statements for any reason. FOR
MORE INFORMATION, PLEASE CONTACT: Elite Financial Communications
Group, LLC Dodi Handy, President and CEO, or Daniel Conway, Chief
Strategy Officer 407-585-1080 or via email at DATASOURCE: Milestone
Scientific Inc. CONTACT: Dodi Handy, President and CEO, or Daniel
Conway, Chief Strategy Officer, both of Elite Financial
Communications Group, LLC, +1-407-585-1080, , for Milestone
Scientific Inc. Web site: http://www.milesci.com/
Copyright